glycogen hamilelikte güvenli mi?
Glycogen (CAS 9005-79-2) is a large endogenous branched glucose polymer; there is no harmonised CLP reproductive classification, no SCCS/CIR safety assessment specific to glycogen found, and no peer‑reviewed evidence that topically applied glycogen causes reproductive toxicity. ECHA lists the substance (no harmonised classification). PubMed literature on glycogen relates to its physiological role (e.g., placental/ tissue glycogen) rather than topical toxicity. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.029.700?utm_source=openai))
Pregnancy-safe products containing glycogen










Related ingredients
Frequently asked questions
- glycogen hamilelikte güvenli mi?
- Glycogen (CAS 9005-79-2) is a large endogenous branched glucose polymer; there is no harmonised CLP reproductive classification, no SCCS/CIR safety assessment specific to glycogen found, and no peer‑reviewed evidence that topically applied glycogen causes reproductive toxicity. ECHA lists the substance (no harmonised classification). PubMed literature on glycogen relates to its physiological role (e.g., placental/ tissue glycogen) rather than topical toxicity. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.029.700?utm_source=openai))
- glycogen emzirirken güvenli mi?
- No evidence that topical glycogen poses hazards to lactation or nursing infants. Glycogen is an endogenous, high‑molecular‑weight polysaccharide; there are no reports of systemic reproductive or lactational toxicity from topical use in the sources searched (no SCCS/CIR opinion, no harmonised CLP). ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.029.700?utm_source=openai))
- glycogen bebek cildi için güvenli mi?
- Hazard and mechanism: no evidence of intrinsic developmental/teratogenic hazard or endocrine activity. Exposure: because glycogen is a very large, highly hydrophilic polymer it is expected to have negligible dermal penetration in adults; for infants (0–3 yr) immature barrier and higher surface‑area‑to‑weight justify a conservative small increase in exposure score (+1) though still low absolute absorption. No infant‑specific adverse data were found. ([pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/Glycogen))
- VeriMom glycogen nasıl puanlıyor?
- VeriMom glycogen'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte glycogen yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.